7Baggers

We provide you with 20 years of free, institutional-grade data for GALT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GALT. Explore the full financial landscape of GALT stock.

Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
NameActionSharesAvg PriceAmountReported Date
ELDRED KARYOpen Market Purchase1,400$3.732025-12-23
FREEMAN KEVIN DOpen Market Purchase16,500$3.552025-12-23
Shlevin Harold H.Sale-24,499$7.04$172,4242025-12-19
Shlevin Harold H.Derivatives Exercise20,0002025-12-19
LEWIS JOELSale-7,829$7.06$55,2412025-12-19
LEWIS JOELDerivatives Exercise7,8292025-12-19
Jamil KhurramDerivatives Exercise14,9632025-12-19
Jamil KhurramSale-19,442$7.04$136,8722025-12-19
10X Fund, L.P.Sale-30,681$6.66$204,3352025-12-18
Shlevin Harold H.Sale-28,210$6.27$176,9902025-12-16
Shlevin Harold H.Derivatives Exercise19,7932025-12-16
Shlevin Harold H.Derivatives Exercise171,7902025-12-10
Shlevin Harold H.Sale-175,790$6$1,055,6192025-12-10
10X Fund, L.P.Sale-162,069$5.47$886,5172025-12-08
10X Fund, L.P.Sale-150,000$5.47$820,5002025-12-04
LEWIS JOELSale-22,463$6.04$135,5842025-11-19
LEWIS JOELDerivatives Exercise22,4632025-11-19
CALLICUTT JACK WSale-77,920$6.03$469,9902025-11-19
CALLICUTT JACK WDerivatives Exercise59,7302025-11-19
Jamil KhurramDerivatives Exercise99,2502025-11-14
Jamil KhurramSale-121,117$5.47$662,5102025-11-14
10X Fund, L.P.Sale-40,000$5.25$210,0002025-11-12
LEWIS JOELSale-1,867$6.03$11,2522025-11-12
LEWIS JOELDerivatives Exercise1,8672025-11-12
CALLICUTT JACK WSale-5,291$6.02$31,8622025-11-12
CALLICUTT JACK WDerivatives Exercise5,2912025-11-12
LEWIS JOELSale-200$6$1,2002025-11-07
LEWIS JOELDerivatives Exercise2002025-11-07
CALLICUTT JACK WSale-600$6$3,6002025-11-07
CALLICUTT JACK WDerivatives Exercise6002025-11-07
CALLICUTT JACK WSale-31,189$6.01$187,4462025-11-05
CALLICUTT JACK WDerivatives Exercise32,4392025-11-05
LEWIS JOELSale-15,720$6.01$94,4772025-11-05
LEWIS JOELDerivatives Exercise15,7202025-11-05
10X Fund, L.P.Sale-50,000$4.93$246,5002025-10-24
CALLICUTT JACK WSale-8,706$6.44$56,0542025-09-15
CALLICUTT JACK WDerivatives Exercise8,7062025-09-15
LEWIS JOELSale-14,000$6.36$89,0482025-09-15
LEWIS JOELDerivatives Exercise14,0002025-09-15
ELDRED KARYOpen Market Purchase1,000$2.922025-07-22
FREEMAN KEVIN DOpen Market Purchase5,000$2.92025-07-18
CZIRR JAMES CDerivatives Exercise323,1252025-06-11
LEWIS JOELGrant, award...etc-56,420$1.57$88,5792025-03-05
Uihlein Richard EGrant, award...etc32,520$1.232025-01-27
Shlevin Harold H.Open Market Purchase6,500$1.162024-12-31
LEWIS JOELSale-56,000$0.89$49,6102024-12-26
LEWIS JOELDerivatives Exercise56,0002024-12-26
Jamil KhurramSale-13,654$0.88$12,0442024-12-26
Jamil KhurramDerivatives Exercise40,0002024-12-26
CALLICUTT JACK WSale-40,000$0.89$35,4922024-12-26
CALLICUTT JACK WDerivatives Exercise40,0002024-12-26
Zordani Richard A. Jr.Open Market Purchase10,000$0.822024-12-26
ELDRED KARYOpen Market Purchase13,469$0.822024-12-26
FREEMAN KEVIN DOpen Market Purchase10,000$0.812024-12-26
ELDRED KARYOpen Market Purchase500$2.62024-10-23
FREEMAN KEVIN DOpen Market Purchase1,300$2.642024-10-17
FREEMAN KEVIN DOpen Market Purchase5,000$2.72024-10-16
FREEMAN KEVIN DOpen Market Purchase5,000$2.72024-10-16
Zordani Richard A. Jr.Open Market Purchase1,000$2.32024-08-26
Zordani Richard A. Jr.Open Market Purchase2,500$2.32024-08-26
ELDRED KARYOpen Market Purchase800$2.392024-07-23
FREEMAN KEVIN DOpen Market Purchase2,500$2.382024-06-20
Zordani Richard A. Jr.Open Market Purchase1,000$3.522024-04-30
CZIRR JAMES CSale-25,000$3.06$76,5002024-04-25
LEWIS JOELOpen Market Purchase1,000$3.392024-04-25
FREEMAN KEVIN DOpen Market Purchase2,500$2.982024-04-22
LEWIS JOELGrant, award...etc-152,584$1.96$299,0652024-03-04
Uihlein Richard EGrant, award...etc23,256$1.722024-02-07
ELDRED KARYOpen Market Purchase500$1.792024-01-16
LEWIS JOELGrant, award...etc11,606$1.662024-01-02
LEWIS JOELGrant, award...etc12,042$1.62023-12-18
LEWIS JOELGrant, award...etc9,880$1.952023-12-01
LEWIS JOELGrant, award...etc10,303$1.872023-11-15
LEWIS JOELGrant, award...etc9,444$2.042023-10-31
LEWIS JOELGrant, award...etc19,620$2.012023-10-16
LEWIS JOELGrant, award...etc10,035$1.922023-10-02
Uihlein Richard EDerivatives Exercise02023-09-27
LEWIS JOELGrant, award...etc10,947$1.762023-09-18
LEWIS JOELGrant, award...etc11,010$1.752023-09-01
LEWIS JOELGrant, award...etc12,042$1.62023-08-15
LEWIS JOELGrant, award...etc12,844$1.52023-07-31
ELDRED KARYOpen Market Purchase1,598$1.792023-07-20
LEWIS JOELGrant, award...etc11,820$1.632023-07-17
LEWIS JOELGrant, award...etc13,380$1.442023-07-03
LEWIS JOELGrant, award...etc13,196$1.462023-06-16
LEWIS JOELGrant, award...etc12,272$1.572023-06-01
LEWIS JOELGrant, award...etc11,748$1.642023-05-16
LEWIS JOELGrant, award...etc10,947$1.762023-05-09
LEWIS JOELGrant, award...etc9,585$2.012023-04-17
LEWIS JOELGrant, award...etc9,175$2.12023-04-03
LEWIS JOELGrant, award...etc10,140$1.92023-03-16
LEWIS JOELSale-75,529$2.07$156,3452023-03-02
LEWIS JOELGrant, award...etc9,308$2.072023-03-02
ELDRED KARYOpen Market Purchase1,000$1.592023-02-21
LEWIS JOELOpen Market Purchase1,000$1.522023-02-21
LEWIS JOELGrant, award...etc13,380$1.442023-02-15
LEWIS JOELGrant, award...etc143,836$1.432023-02-07
LEWIS JOELGrant, award...etc15,086$1.162023-01-31
Login to see more insider transactions
The information provided in this report about GALT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Galectin Therapeutics Inc
(NASDAQ:GALT) 

GALT stock logo

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is (GR-MD-02) belapectin galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharid...

Founded: 2000
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends